Royal Bank of Canada’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,694
| Closed | -$23K | – | 6341 |
|
|
2024
Q2 | $23K | Buy |
5,694
+3,124
| +122% | +$12.6K | ﹤0.01% | 5615 |
|
|
2024
Q1 | $17K | Sell |
2,570
-41,455
| -94% | -$274K | ﹤0.01% | 5535 |
|
|
2023
Q4 | $207K | Buy |
44,025
+43,708
| +13,788% | +$206K | ﹤0.01% | 4553 |
|
|
2023
Q3 | $1K | Buy |
317
+194
| +158% | +$612 | ﹤0.01% | 6355 |
|
|
2023
Q2 | $0 | Buy |
123
+100
| +435% | – | ﹤0.01% | 6748 |
|
|
2023
Q1 | $0 | Buy |
+23
| New | – | ﹤0.01% | 6635 |
|
|
2022
Q2 | – | Sell |
-585
| Closed | -$22K | – | 6864 |
|
|
2022
Q1 | $22K | Hold |
585
| – | – | ﹤0.01% | 6059 |
|
|
2021
Q4 | $34K | Sell |
585
-445
| -43% | -$25.9K | ﹤0.01% | 6039 |
|
|
2021
Q3 | $105K | Sell |
1,030
-28
| -3% | -$2.85K | ﹤0.01% | 5152 |
|
|
2021
Q2 | $104K | Buy |
1,058
+299
| +39% | +$29.4K | ﹤0.01% | 5098 |
|
|
2021
Q1 | $76K | Buy |
759
+329
| +77% | +$32.9K | ﹤0.01% | 5145 |
|
|
2020
Q4 | $42K | Buy |
430
+375
| +682% | +$36.6K | ﹤0.01% | 5188 |
|
|
2020
Q3 | $27K | Buy |
55
+40
| +267% | +$19.6K | ﹤0.01% | 5087 |
|
|
2020
Q2 | $12K | Buy |
15
+14
| +1,400% | +$11.2K | ﹤0.01% | 5287 |
|
|
2020
Q1 | $1K | Sell |
1
-6
| -86% | -$6K | ﹤0.01% | 5888 |
|
|
2019
Q4 | $7K | Buy |
+7
| New | +$7K | ﹤0.01% | 5639 |
|